$TKMR Recent Headlines Number of companies fighting

New Post Public Reply Private Reply Replies (0) Message Board

Oct 6, 2014 at 1:26 PM

$TKMR Recent Headlines

Number of companies fighting Ebola grows, one wins fed OK 12:09 p.m. Today - Russ Britt
Tekmira shares slump as Leerink downgrades on valuation grounds 10:23 a.m. Today - Ciara Linnane
Tekmira Pharmaceuticals downgraded to market perform at Leerink 9:00 a.m. Today - Ciara Linnane
10 biggest market-moving events of the week 5:03 p.m. Oct. 3, 2014 - Philip van Doorn
U.S. stocks rally on strong jobs report 4:32 p.m. Oct. 3, 2014 - Sara Sjolin
Meet the drug companies fighting Ebola 4:14 p.m. Oct. 3, 2014 - Russ Britt
RadioShack gets a jolt from financing report; Mylan rises 8:22 a.m. Oct. 3, 2014 - Sue Chang
Ebola play Tekmira Pharmaceuticals shares drop 2.4% 9:35 a.m. Oct. 2, 2014 - Sue Chang
Newscast: Stocks swoon to start October 6:27 p.m. Oct. 1, 2014 - MarketWatch
U.S. stocks skid; Russell 2000 in correction territory 4:34 p.m. Oct. 1, 2014 - Barbara Kollmeyer
Getting Ebola treatments to market may take time 3:04 p.m. Oct. 1, 2014 - Russ Britt
6 stocks to watch 2:08 p.m. Oct. 1, 2014 - The Trading Deck
Tekmira Pharmaceuticals shares jump 20% 9:33 a.m. Oct. 1, 2014 - Sue Chang
Profiting from the fear as the market’s best quarter of the year begins 8:58 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira may launch clinical trial of Ebola drug later this year: RBC 8:19 a.m. Oct. 1, 2014 - Ciara Linnane
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Sue Chang
Tekmira Pharmaceuticals shares up 27% in premarket trade 8:03 a.m. Oct. 1, 2014 - Ciara Linnane
FAA orders screen switch 2:33 a.m. Oct. 1, 2014 - MarketWatch
Tekmira Pharma shares pop on first U.S. Ebola case 7:43 p.m. Sept. 30, 2014 - Wallace Witkowski
Newscast: Wall Street notches winning quarter 6:31 p.m. Sept. 30, 2014 - MarketWatch

Why Tekmira Pharmaceuticals (TKMR) Stock Is Tanking Today 10:17 a.m. Today - TheStreet.com
Tekmira Pharmaceuticals (TKMR) Is Weak On High Volume Today 10:01 a.m. Today - TheStreet.com
'Fast Money' Recap: Roller-Coaster Week Ends With a Rally 5:00 a.m. Oct. 4, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:09 p.m. Oct. 3, 2014 - TheStreet.com
Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining Today 10:56 a.m. Oct. 3, 2014 - TheStreet.com
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Oct. 2, 2014 - Seeking Alpha
Tekmira Pharmaceuticals (TKMR) Is Today's Perilous Reversal Stock 9:48 a.m. Oct. 2, 2014 - TheStreet.com
Thumbs Up for REITs, Down for Ebola Stocks? 7:42 a.m. Oct. 2, 2014 - Barrons.com
Making Money With Charles Payne: 10/01/14 6:00 p.m. Oct. 1, 2014 - FOXBusiness
Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% 4:39 p.m. Oct. 1, 2014 - GuruFocus.com
Stock Market Today: Stocks Dive With Utilities the Only Winning Sector 4:36 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Dow Drops 250 Points as Trouble Brews 3:29 p.m. Oct. 1, 2014 - TheStreet.com
3 Stocks Soaring on Spread of Ebola Virus Epidemic - Stocks in the News 1:48 p.m. Oct. 1, 2014 - Zacks.com
Ebola-Related Pharma Stocks Soar On First U.S. Case 1:20 p.m. Oct. 1, 2014 - Investors Business Daily
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today 12:22 p.m. Oct. 1, 2014 - TheStreet.com
Stock Market Today: Stocks Decline as Investors Remain Uneasy 11:41 a.m. Oct. 1, 2014 - TheStreet.com
Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks 10:08 a.m. Oct. 1, 2014 - TheStreet.com
Today's Market: Biotech Stocks To Buy For Their Ebola Vaccines 9:35 a.m. Oct. 1, 2014 - Seeking Alpha
Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open 8:22 a.m. Oct. 1, 2014 - TheStreet.com
5 Ebola Stocks – Invest in Preventing a U.S. Ebola Outbreak 5:13 a.m. Oct. 1, 2014 - InvestorPlace.com

What's Next: Investors Place Ebola Pandemic Stock Bets 7:59 a.m. Today - ACCESSWIRE
Tekmira to Present at BIO Investor Forum 11:46 p.m. Oct. 2, 2014 - GlobeNewswire
Tekmira Achieves $1.5 Million Development Milestone 7:01 p.m. Oct. 2, 2014 - GlobeNewswire
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:11 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

iTLC Traffic Systems Expand Global Reach at APTA 2026

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Main Street Merger Faces Scrutiny: What It Means for Shareholders

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

UBCF Strikes Big in Times Square with New Billboards

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

NIDS Aims Global with CES 2027, Boosts Sensor Supply

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...